OraQuick(R) In-Home HIV Test Named a "Top Health Breakthrough of 2012" by Men's Health Magazine

OraQuick(R) In-Home HIV Test Named a "Top Health Breakthrough of 2012" by
Men's Health Magazine

BETHLEHEM, Pa., Feb. 14, 2013 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc.
(Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today
that the Company's OraQuick® In-Home HIV Test, the first ever in-home rapid
infectious disease test made available directly to consumers, has been named a
"Top Health Breakthrough of 2012" by Men's Health magazine. The OraQuick®
In-Home HIV Test was listed as the #1 breakthrough on this list for 2012.

The OraQuick® In-Home HIV Test, approved by the U.S. Food and Drug
Administration (FDA) in July 2012, detects antibodies to both HIV-1 and HIV-2
with an oral swab, providing a confidential in-home testing option with
results in as little as 20 minutes. The in-home test, which is now available
at major retailers nationwide, is an over-the-counter version of OraQuick
ADVANCE®, an oral swab rapid test with more than 25 million units sold in the
professional market, including doctors, hospitals, clinics and other trained
professionals. The OraQuick In-Home HIV Test is available at thousands of
retailers nationwide and online at OraQuick.com.

To ensure optimal support for individuals using the OraQuick® In-Home HIV
Test, OraSure offers live support and comprehensive referral services 24 hours
a day, seven days a week, every day of the year, through a toll-free support
center and comprehensive consumer website. The OraQuick® Support Center is
staffed with highly trained, bi-lingual (English/Spanish) representatives who
are available by telephone at 866-436-6527 to answer questions about HIV/AIDS
and using and interpreting the test. They also provide referrals to follow-up
and care, and can take orders for the OraQuick In-Home HIV Test. Additionally,
the product website provides access to resources and referral to follow-up
counseling, confirmatory testing and medical care.

Visit OraQuick.com for more information.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and
distribution of oral fluid diagnostic and collection devices and other
technologies designed to detect or diagnose critical medical conditions. Its
innovative products include rapid tests for the detection of antibodies to HIV
and HCV at the point of care and testing solutions for detecting various drugs
of abuse. In July 2012, the Company received approval from the U.S. Food and
Drug Administration for the Company's OraQuick® In-Home HIV Test for sale
directly to consumers in the over-the-counter (OTC) market - making it the
first and only rapid OTC HIV test approved in the U.S. In addition, the
Company is a leading provider of oral fluid sample collection, stabilization
and preparation products for molecular diagnostic applications. OraSure's
portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health
organizations, research and academic institutions, distributors, government
agencies, physicians' offices, and commercial and industrial entities. The
Company's products enable healthcare providers to deliver critical information
to patients, empowering them to make decisions to improve and protect their
health.

For more information on OraSure Technologies, please visit www.orasure.com.

The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440

CONTACT: Media Contact:
         Jennifer Moritz
         Zer0 to 5ive for OraSure Technologies
         917-748-4006
         jmoritz@0to5.com

company logo
 
Press spacebar to pause and continue. Press esc to stop.